In partnership with
November 28, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today we stay with the hemp language that slipped into the spending talks and watch how it collides with holiday shopping, state politics, federal health policy, and a growing set of legal and financial guardrails. Today’s edition is supported by AG1, Morning Brew, and The Deep View. Their support keeps this project free for you.
If you need something for the drive or the dishes, you can always stream The Hybrid’s Thanksgiving side dish draft, where two former regulators argue about stuffing, sideboards, and what this industry can still be thankful for this year.
🧩 Hemp clampdown collides with everyday holiday shopping
⚖️ The reshaping of cannabis revenue and risk
🦃 Green Wednesday habits
Stay ready; the quiet days are when the rules move fastest.
Don't wait until New Years to take control of your health.
Every year it’s the same - November comes, the days get dark and cold, you start skipping your morning workout, and you start to lose control of your health habits.
It’s easy to think “I’ll worry about getting back on track next year” - but there’s no reason you can’t get a head start now.
You just need a daily health habit that’s ACTUALLY easy to stick with.
That’s where AG1 comes in. With just one quick scoop every morning, you’ll get over 75 ingredients that help support your immune health, gut health, energy, and close nutrient gaps in your diet.
Right now is the best time to get started - with every new subscription, they are giving away $126 in free gifts for the holidays.
Give AG1 a try today and take back control of your health this holiday season.
Start here — the day’s most important development, decoded for impact.
Congress’s Hemp Clampdown Meets A Normalized Market
📌 What Happened: We have been living with this hemp story since Congress tucked it into the shutdown talks, and the plot keeps adding new characters. The spending deal that finally passed did more than keep the federal government’s lights on, it imposed a functional national cap on intoxicating hemp by tying legality to 0.4 milligrams of THC per container and starting a one year countdown. Minnesota’s federal delegation stepped up first, arguing that Congress should not erase a state hemp beverage market that already runs on age checks, testing, and labeling, and offering their rules as a template or at least a safe harbor. In Florida, Nikki Fried is treating the same language as proof that Washington just kneecapped a functioning industry, and she is folding that line into a 2026 legalization push built on jobs, small business stories, and senior voters. FundCanna’s Adam Stettner has joined in with an op ed that calls the move economic self harm and lays out a national framework that focuses on potency limits and enforcement instead of bans. At the same time, CMS floated draft rules that would allow Medicare plans to cover compliant CBD products, which means one arm of the federal government is starting to build a benefit around hemp while another arm narrows the definition of what counts as legal.
💡 Why It Matters: The country now has a federal statute that treats most intoxicating hemp products as a problem at the exact moment millions of people treat them as part of a normal shopping trip. State systems such as Minnesota’s hemp beverage rules and Florida’s emerging adult use campaign do not live in theory anymore, they live in breweries, grocery coolers, and bar programs that built real payrolls around the 2018 Farm Bill. The Green Wednesday crowds in Maryland, where families picked up both dispensary flower and hemp drinks on the way to Thanksgiving, show how deeply these products have moved into holiday rituals and everyday life. That reality gives advocates something more concrete than abstractions about “loopholes,” because members of Congress now have to explain a rule that tells voters their favorite seltzer or gummy was a mistake. The one year clock also forces coordination across committees and agencies, since any serious fix will have to reconcile health policy, agriculture politics, tax expectations, and public safety concerns in a single narrative. Anyone setting strategy around cannabinoids in mainstream retail now has to treat this process as a central planning assumption rather than background chatter.
🧠 THC Group Take: Leave it to Congress to solve one “problem” only to create another, possibly bigger, one. Minnesota’s delegation is offering leadership a way to say they listened, pointing to a working state framework with age checks, testing, and a tax base that mayors can describe in plain numbers. Nikki Fried is hoping to turn Florida into a pressure cooker, because every small town hardware store and strip mall shop that added a hemp cooler now has a payroll story that does not line up with the vote tally in Washington. Stettner and the capital side of the industry are giving staff the kind of hard numbers they actually plug into amendment memos and whip talking points. CMS, naturally, has added its own wrinkle by signaling that some hemp products belong in Medicare benefit design even as Congress tightens the definition of what qualifies, a familiar federal crosscurrent. The opening now is to treat this year as organizing time, gather stories from retailers, seniors, veterans, manufacturers, farmers, and landlords, and show how many parts of normal life sit inside the hemp economy. A coalition that runs from clinic waiting rooms to liquor aisles and taprooms can press for clear, adult-use rules and turn a rushed prohibition into a quieter movement for standards that voters actually recognize as fair.
Fast-moving headlines, flagged for what matters.
Lines wrapped through a Maryland dispensary on Green Wednesday as customers stocked up on edibles, prerolls, and even 100 dollar "Queen Cola" top colas that sold out in minutes. The day now rivals 4/20 for peak sales, with operators treating it as the start of a holiday season that pulls in occasional users, visiting relatives, and multi generational family groups who build cannabis into their Thanksgiving rituals. Industry advocates point to a 34 billion dollar cannabis market and a 28 billion dollar hemp derived products market as proof that normalization has moved from subculture to family table, even though federal law still labels marijuana a Schedule I drug. The new federal spending bill includes a one year deadline to close the hemp "loophole," and many Green Wednesday baskets now include intoxicating hemp products sold in liquor and grocery channels that could vanish or migrate into licensed systems. The kitchens in Silver Spring and across the D.C. region tell the story of a cultural shift that is arriving faster than the legal map underneath it. (The Washington Post)
Minnesota’s Democratic delegation is moving to unwind the new federal hemp THC ban that came through in the latest spending bill, and they are framing it as an urgent threat to farmers, breweries, and small beverage businesses in a state that already runs a structured adult use hemp regime. Sens. Amy Klobuchar and Tina Smith joined Rep. Ilhan Omar at a press conference to argue for replacing the blanket ban with a national framework modeled on Minnesota’s guardrails for age limits, labeling, and testing, or at least carving out space for compliant state programs. They are eyeing a skinny Farm Bill and other agriculture vehicles as paths to amend the law before the one year clock runs out. At the same time, Sen. Rand Paul is preparing legislation that would let state hemp rules supersede the new federal standard. Omar says her office is already working House GOP leadership, including Majority Whip Tom Emmer, who she describes as receptive given the industry’s role in Minnesota’s economy. The strategy now hinges on how quickly lawmakers can turn local job and tax stories into bipartisan cover for undoing a prohibition they helped pass in the rush to keep the government open. (Marijuana Moment)
Florida Democratic Party chair Nikki Fried is using the new federal hemp ban as a foil for a broader message that Congress just killed an entire industry without understanding what it built. She tells Marijuana Moment she expects lawmakers to have no choice but to revisit the law once they hear from the small farmers, seniors, veterans, and shop owners whose livelihoods now sit on a one year implementation clock. Fried leans on her agriculture commissioner credentials to argue for tighter testing, QR codes, and age limits instead of prohibition, and she frames the fight as a 400 thousand job, 50 billion dollar economic story that crosses party lines. She also projects confidence that Florida voters will approve adult use legalization in 2026 once the current ballot language litigation runs its course, positioning cannabis as a mainstream economic plank rather than a niche cultural issue. Her posture sketches a campaign playbook that mixes populist anger at late night procedural votes with a regulatory path forward and a high stakes ballot fight in a state both parties treat as essential. (Marijuana Moment)
A new Marijuana Moment op ed from FundCanna CEO Adam Stettner argues that Congress quietly used the federal budget deal to dismantle a 28 to 30 billion dollar hemp market while presenting the move as a public safety fix. He warns that the 0.4 milligram per container THC cap would wipe out an estimated 95 percent of hemp derived products, erase hundreds of thousands of jobs, and push activity into illicit channels instead of isolating bad actors. Stettner calls for a national framework built on potency limits, lab testing, packaging rules, age gating, and enforceable distribution standards rather than blanket prohibition. He presents the hemp sector as one of the only functioning national pathways toward regulated cannabinoid access and urges lawmakers to treat it like alcohol and tobacco, tightly supervised instead of casually erased in fine print. The argument lands as a reminder that prohibiting most of a market does not remove demand, it simply shifts safety problems into places where regulators and law enforcement have less visibility. (Adam Stettner, Marijuana Moment op-ed)
A new CMS proposal would let Medicare plans cover CBD and other hemp derived products that are legal under federal and state law, reversing a 2026 rule that barred cannabis products altogether. The draft language, set for Federal Register publication, narrows the exclusion to products that are illegal under applicable law, which opens space for compliant hemp and certain hemp seed products already deemed generally recognized as safe by FDA. Bloomberg reporting suggests early implementation could focus on oncology and palliative care patients and frames the move as part of a broader benefits rule that also touches marketing, drug coverage, and enrollment standards. The timing overlaps with HHS Secretary Robert F. Kennedy Jr. meeting Commonwealth Project CEO Howard Kessler, whose pro CBD Medicare video later appeared on Donald Trump’s social media feed. CMS still flags the looming federal hemp clampdown and evolving state laws as key constraints, so any CBD benefit design will live inside a moving definition of what counts as a legal product. For plans and manufacturers, the signal is that cannabinoid coverage now belongs in strategic planning, but only for products that can thread an increasingly narrow regulatory path. (Marijuana Moment)
A Cato Institute amicus brief is urging the U.S. Supreme Court to take Canna Provisions v. Bondi and use it to reset the Commerce Clause line that has supported federal marijuana prohibition since Raich. The filing leans into federalism, arguing that the Controlled Substances Act’s reach into intrastate, state licensed cannabis markets turns Congress’s commerce power into a national police power and erases structural limits that protect state autonomy. It points to Massachusetts’s seed to sale system as an example of purely intrastate activity that never crosses a state border and argues that criminalizing that activity regulates agriculture, manufacturing, and consumption rather than interstate trade. The brief arrives as DOJ declines to weigh in on cert and as the Court schedules a closed door conference on the petition, with at least four votes needed to move the case forward. With Americans for Prosperity Foundation filing its own amicus and Justice Thomas already on record questioning the logic of Raich, industry lawyers see a narrow but realistic opening for the Court to revisit how far Congress can go when states run their own marijuana experiments. (Marijuana Moment)
A new JAMA review consolidates clinical evidence and concludes that cannabis and cannabinoids have solid support only in a narrow set of indications such as HIV or AIDS related anorexia, chemotherapy induced nausea and vomiting, and certain pediatric seizure disorders. It highlights small to moderate benefits for appetite and nausea control and finds insufficient trial data for many popular claims, including acute pain and insomnia. The authors emphasize rising concern around high potency products, linking stronger THC exposure to higher rates of psychotic symptoms, anxiety, cannabis use disorder, and cardiovascular events in daily inhaled users. They urge clinicians to screen for contraindications such as pregnancy, schizophrenia, and ischemic heart disease before considering cannabis as a therapeutic option and to give explicit harm reduction guidance on dosing, polysubstance use, and driving. For policymakers and regulators, the article offers a mainstream clinical benchmark that will shape medical guidelines, insurer coverage decisions, and liability expectations as states revisit what they describe as medical cannabis in broadly adult use markets. (JAMA)
Illinois is on pace to collect less recreational cannabis tax revenue for the second time in three years as wholesale and retail prices continue to drift downward. Through October, state receipts from adult use sales sit about two percent below the same point last year, according to Comptroller data highlighted by Crain’s, even though the market is larger and more mature. The effective tax base is shrinking as operators discount to compete with each other, chase price sensitive consumers, and respond to cheaper product in neighboring states such as Michigan and Missouri. Lower per unit prices help regular consumers and patients, but they also expose how dependent Illinois became on early years margins that were never going to last. Budget writers and regulators now face a choice between tightening fiscal expectations, revisiting the tax mix, or trying to manage cross border arbitrage instead of assuming cannabis revenue will quietly fill every gap. (Crain’s Chicago Business)
Michigan’s Court of Claims just heard arguments on a new 24 percent wholesale cannabis tax that industry groups say violates the state constitution and the 2018 voter initiative that set a 10 percent excise tax. The levy, built into the state’s fiscal 2026 budget, aims to raise roughly 420 million dollars for roads and infrastructure at the same time that Michigan’s market wrestles with oversupply, price compression, and thin margins. The Michigan Cannabis Industry Association argues that lawmakers effectively amended the voter approved framework without the supermajority required for changes to a citizen initiative. State lawyers respond that this is a separate wholesale tax layered alongside the original statute, not an amendment. With Judge Sima Patel expected to rule soon and both sides already looking toward the Michigan Supreme Court, the case will test how far legislators can lean on cannabis revenue once markets mature faster than the budgets that depend on them. (MJBizDaily)
Canadian specialty markets are still patching coverage gaps for cannabis even after years of legalization, and that struggle is teaching insurers how to handle the next wave of unconventional risks. Special Risk Insurance Managers’ CEO describes a sector where traditional tools such as COPE checklists and loss histories never fit cleanly, which led carriers to stack exclusions, narrow sublimits, and crime coverage that lives or dies on physical security. Business interruption and product liability remain especially murky, with recall insurance described as evasive despite maturing operations and more predictable loss patterns. The upside for cannabis is that this difficult underwriting apprenticeship now informs playbooks for crypto, psychedelics, and other regulated edge cases where regulators gradually standardize behavior and make risk more legible. On the ground, that still translates into a hard market with limited carrier appetite, and each new rule set or enforcement pattern becomes a small test of whether underwriters are ready to open more capacity or keep treating cannabis as a permanent outlier. (Insurance Business Canada)
A group of cannabis workers has reached a settlement in a wage and hour lawsuit that accused their employer of imposing aggressive production quotas and failing to pay for all hours worked. Court filings describe a workplace where meeting metrics allegedly pushed staff into off the clock labor and blurred the line between scheduled shifts and mandatory tasks. The resolution avoids a trial that might have opened company timekeeping, security procedures, and production targets to broader public scrutiny. For other employers, the case reads as a warning that overtime rules, meal and rest breaks, and quota systems will face the same plaintiff scrutiny in cannabis as in warehouses or meatpacking plants. It underscores a basic operational truth for this industry: labor compliance now sits alongside licensing and track and trace as a core risk area rather than a secondary afterthought. (Law360)
A California bankruptcy court has ruled that a failed cannabis venture built around Green Acre Pharms was fraudulent from the start, leaving investors out millions and turning one family’s fire insurance payout into a dead end. Acting through Renewable Technology Solutions, Guy Griffithe sold slivers of supposed ownership in a Washington grow operation, sent quarterly checks to early investors, and then watched the payments stop once new money dried up. The SEC later described the setup as Ponzi like, alleging that at least 25 investors were defrauded out of 4.85 million dollars and that funds went to other investors and Griffithe’s personal expenses rather than a functioning cannabis business. After Griffithe landed in Chapter 7, the court held a three day trial and found that the debt to one investor family could not be washed away in bankruptcy because the offering violated federal and Washington securities laws and met the standard for per se fraud. The appellate panel affirmed and rejected arguments that an SEC settlement and state court dismissal should insulate him from further judgment, and anyone raising capital around cannabis ventures now has another detailed example of what regulators and judges will treat as unforgivable. (Investment News)
All the news that matters to your career & life
Hyper-relevant news. Bite-sized stories. Written with personality. And games that’ll keep you coming back.
Morning Brew is the go-to newsletter for anyone who wants to stay on top of the world’s most pressing stories — in a quick, witty, and actually enjoyable way. If it impacts your career or life, you can bet it’s covered in the Brew — with a few puns sprinkled in to keep things interesting.
Join over 4 million people who read Morning Brew every day, and start your mornings with the news that matters most — minus the boring stuff.
From the hearing room to the comment section — we’re watching it all.
🍁 A round of Thanksgiving reflections from GreenState becomes a small roll call of what keeps people in this industry from burning out. Founders, consultants, journalists, and marketers talk about remission from illness, long haul friendships, Tribal partnerships, goofy golf tournaments, weed witches, and food drives that fill local pantries. The through line feels simple and steady: this work still has human weight and lets people build a life that feels like their own. (GreenState)
🎖️ Ottawa’s plan to save $4.4 billion by trimming veterans’ medical cannabis reimbursement to $6 a gram from $8.50 is running into math and politics at the same time. Critics note that Veterans Affairs Canada took 13 years to cross $1 billion in reimbursements and say the projected savings look more like a broad VAC budget cut dressed up as cannabis policy. Thousands of veterans are left wondering how far their prescriptions and monthly costs will shift in the name of discipline on paper. (StratCann)
🐶 A British health piece profiles anxious and aggressive dogs whose owners swear by cannabis derived extracts that help them settle. The products sit in a gray zone where marketing spreads faster than evidence, and dosing standards lag behind household adoption. Regulators and veterinarians now have to decide how far they want to chase a pet market that increasingly copies human CBD habits. (The Sun (UK))
🎬 An Inlander Green Zone feature checks in with Seth Rogen, one of pop culture’s defining on screen stoners, a person who helped turn cannabis into a punchline long before it became a budget line. The portrait lands at the stage of life where health, family, and reputation all sit in the same frame as a long public relationship with weed. It feels like a quiet reminder that the people who once made cannabis a joke now live inside a market that finally takes the plant, and their choices, seriously. (Inlander, Green Zone)
📬 Court records describe a Bloomington postal worker who called herself a kleptomaniac after allegedly skimming packages she thought held weed and burning more than 1,000 pieces of mail to hide it. The case is a small, messy story that shows how far cannabis drifts from any regulated system once it moves through the federal mail instead of a licensed supply chain. (WTHR)
The AI Insights Every Decision Maker Needs
You control budgets, manage pipelines, and make decisions, but you still have trouble keeping up with everything going on in AI. If that sounds like you, don’t worry, you’re not alone – and The Deep View is here to help.
This free, 5-minute-long daily newsletter covers everything you need to know about AI. The biggest developments, the most pressing issues, and how companies from Google and Meta to the hottest startups are using it to reshape their businesses… it’s all broken down for you each and every morning into easy-to-digest snippets.
If you want to up your AI knowledge and stay on the forefront of the industry, you can subscribe to The Deep View right here (it’s free!).